Literature DB >> 7644063

Long-duration response to levodopa.

J G Nutt1, J H Carter, W R Woodward.   

Abstract

We measured the long-duration response to levodopa by changes in tapping rate in 16 patients with Parkinson's disease undergoing 3 to 5 days of levodopa withdrawal. "Off" tapping rates deteriorated 22% over the course of this holiday, the decline beginning 24 hours after levodopa withdrawal. Deterioration was more pronounced in the more affected hand in asymmetrically affected patients. A 2-hour infusion of levodopa after the levodopa holiday did not restore the long-duration response, although it produced a greater short-duration response than before the holiday. These observations indicate that the long-duration response is an important component of the therapeutic benefit of levodopa and is separable from the short-duration response.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7644063     DOI: 10.1212/wnl.45.8.1613

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  16 in total

1.  Dopamine-dependent motor learning: insight into levodopa's long-duration response.

Authors:  Jeff A Beeler; Zhen Fang Huang Cao; Mazen A Kheirbek; Yunmin Ding; Jessica Koranda; Mari Murakami; Un Jung Kang; Xiaoxi Zhuang
Journal:  Ann Neurol       Date:  2010-05       Impact factor: 10.422

2.  The effect of levodopa therapy on dopamine transporter SPECT imaging with( 123)I-FP-CIT in patients with Parkinson's disease.

Authors:  Orazio Schillaci; Mariangela Pierantozzi; Luca Filippi; Carlo Manni; Livia Brusa; Roberta Danieli; Giorgio Bernardi; Giovanni Simonetti; Paolo Stanzione
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-09-08       Impact factor: 9.236

Review 3.  Preservation of function in Parkinson's disease: what's learning got to do with it?

Authors:  Jeff A Beeler
Journal:  Brain Res       Date:  2011-09-29       Impact factor: 3.252

4.  Modeling the short- and long-duration responses to exogenous levodopa and to endogenous levodopa production in Parkinson's disease.

Authors:  Phylinda L S Chan; John G Nutt; Nicholas H G Holford
Journal:  J Pharmacokinet Pharmacodyn       Date:  2004-06       Impact factor: 2.745

5.  Paradoxical effect of dopamine medication on cognition in Parkinson's disease: relationship to side of motor onset.

Authors:  Brenda Hanna-Pladdy; Rajesh Pahwa; Kelly E Lyons
Journal:  J Int Neuropsychol Soc       Date:  2015-04-29       Impact factor: 2.892

Review 6.  The role of the long-duration response to levodopa in Parkinson's disease.

Authors:  Mario Zappia; Alessandra Nicoletti
Journal:  J Neurol       Date:  2010-11       Impact factor: 4.849

Review 7.  The missing, the short, and the long: Levodopa responses and dopamine actions.

Authors:  Roger L Albin; Daniel K Leventhal
Journal:  Ann Neurol       Date:  2017-06-05       Impact factor: 10.422

8.  A Fuzzy Inference System for Closed-Loop Deep Brain Stimulation in Parkinson's Disease.

Authors:  Carmen Camara; Kevin Warwick; Ricardo Bruña; Tipu Aziz; Francisco del Pozo; Fernando Maestú
Journal:  J Med Syst       Date:  2015-09-18       Impact factor: 4.460

9.  Sensitivity and specificity of the finger tapping task for the detection of psychogenic movement disorders.

Authors:  Susan Criswell; Callen Sterling; Laura Swisher; Brad Evanoff; Brad A Racette
Journal:  Parkinsonism Relat Disord       Date:  2009-12-14       Impact factor: 4.891

10.  High-frequency stimulation of the subthalamic nucleus prolongs the increase in striatal dopamine induced by acute l-3,4-dihydroxyphenylalanine in dopaminergic denervated rats.

Authors:  Emilie Lacombe; Carole Carcenac; Sabrina Boulet; Claude Feuerstein; Anne Bertrand; Annie Poupard; Marc Savasta
Journal:  Eur J Neurosci       Date:  2007-09-06       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.